Portal de Periódicos da CAPES

Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe

2019; American Society for Microbiology; Volume: 4; Issue: 6 Linguagem: Inglês

10.1128/msphere.00455-19

2379-5042

Bob Meek, Nina Ekström, Bjørn Kantsø, Rachael Almond, Jamie Findlow, Jenna F. Gritzfeld, Charlotte Sværke Jørgensen, Karl Ljungberg, Fredrik Atterfelt, Manou R. Batstra, Kevin Andeweg, B.A.W. de Jong, Harry E. Prince, Mary Lapé-Nixon, Pieter G. M. van Gageldonk, Irina Tcherniaeva, Ingeborg S. Aaberge, Tove Karin Herstad, Merit Melin, Ger T. Rijkers, Guy A. M. Berbers,

Bacterial Infections and Vaccines

Serology of Streptococcus pneumoniae is challenging due to existence of multiple clinically relevant serotypes and the introduction of multivalent vaccines in national immunization programs. Multiplex immunoassays (MIAs) are applied as high-throughput cost-effective methods for serosurveillance, and yet laboratories use their own protocols. The aims of this study were to assess the agreement of results generated by MIAs in different laboratories within the EU Pneumo Multiplex Assay Consortium, to analyze factors contributing to differences in outcome, and to create a harmonized protocol. The study demonstrated good agreement of results of MIAs performed by laboratories using controlled assays for determination of levels of vaccine-induced pneumococcal antibodies. The EU Pneumo Multiplex Assay Consortium is open to everyone working in public health services, and it aims to facilitate efforts by participants to run and maintain a cost-effective, reproducible, high-quality MIA platform.